A citation-based method for searching scientific literature

Lucile Bussot, Simon Chevalier, Justine Cristante, Béatrice Grange, Bruno Tesson, Clémence Deteix-Santana, Frédérique Orsini-Piocelle, Cécile Leyronnas, Sophie Dupire, Rémy Gressin, Gilles Salles, Emmanuel Bachy, Anouk Emadali, Séverine Valmary-Degano, Sarah Huet, Christine Lefebvre, Sylvain Carras. Br J Haematol 2021
Times Cited: 2







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
641
100

The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Brett Collinge, Susana Ben-Neriah, Lauren Chong, Merrill Boyle, Aixiang Jiang, Tomoko Miyata-Takata, Pedro Farinha, Jeffrey W Craig, Graham W Slack, Daisuke Ennishi,[...]. Blood 2021
14
100

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
100

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
C M Eischen, J D Weber, M F Roussel, C J Sherr, J L Cleveland. Genes Dev 1999
672
50

"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
Elise Chapiro, Claude Lesty, Clémentine Gabillaud, Eric Durot, Simon Bouzy, Marine Armand, Magali Le Garff-Tavernier, Nadia Bougacha, Stéphanie Struski, Audrey Bidet,[...]. Am J Hematol 2018
8
50

miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.
Marek Mraz, Liguang Chen, Laura Z Rassenti, Emanuela M Ghia, Hongying Li, Kristen Jepsen, Erin N Smith, Karen Messer, Kelly A Frazer, Thomas J Kipps. Blood 2014
108
50

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
J Malcikova, E Tausch, D Rossi, L A Sutton, T Soussi, T Zenz, A P Kater, C U Niemann, D Gonzalez, F Davi,[...]. Leukemia 2018
101
50

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
Andrea Rinaldi, Michael Mian, Ivo Kwee, Davide Rossi, Clara Deambrogi, Afua A Mensah, Francesco Forconi, Valeria Spina, Emanuele Cencini, Daniela Drandi,[...]. Br J Haematol 2011
32
50

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
Gonzalo Blanco, Anna Puiggros, Panagiotis Baliakas, Anastasia Athanasiadou, MªDolores García-Malo, Rosa Collado, Aliki Xochelli, María Rodríguez-Rivera, Margarita Ortega, Mª José Calasanz,[...]. Oncotarget 2016
20
50

MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.
Katerina Cerna, Jan Oppelt, Vaclav Chochola, Katerina Musilova, Vaclav Seda, Gabriela Pavlasova, Lenka Radova, Maddalena Arigoni, Raffaele A Calogero, Vladimir Benes,[...]. Leukemia 2019
29
50

MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Sabine Haberl, Torsten Haferlach, Anna Stengel, Sabine Jeromin, Wolfgang Kern, Claudia Haferlach. Cancer Genet 2016
8
50

Biology and treatment of Richter syndrome.
Davide Rossi, Valeria Spina, Gianluca Gaidano. Blood 2018
94
50

Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
Francesco Forconi, Andrea Rinaldi, Ivo Kwee, Elisa Sozzi, Donatella Raspadori, Paola M V Rancoita, Marta Scandurra, Davide Rossi, Clara Deambrogi, Daniela Capello,[...]. Br J Haematol 2008
58
50

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Elise Chapiro, Elodie Pramil, M'boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve,[...]. Blood 2019
15
50

Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
Jennifer R Brown, Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M Asara, Yaoyu E Wang, Paola Dal Cin, Stacey M Fernandes, Christina Thompson,[...]. Clin Cancer Res 2012
69
50

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.
Vanessa J Craig, Sergio B Cogliatti, Jochen Imig, Christoph Renner, Stefan Neuenschwander, Hubert Rehrauer, Ralph Schlapbach, Stephan Dirnhofer, Alexander Tzankov, Anne Müller. Blood 2011
135
50

Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.
Jane Houldsworth, Asha Guttapalli, Venkata Thodima, Xiao Jie Yan, Geetu Mendiratta, Tania Zielonka, Gouri Nanjangud, Weiyi Chen, Sujata Patil, Anthony Mato,[...]. Leuk Lymphoma 2014
22
50

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Julio Delgado, Itziar Salaverria, Tycho Baumann, Alejandra Martínez-Trillos, Eriong Lee, Laura Jiménez, Alba Navarro, Cristina Royo, Rodrigo Santacruz, Cristina López,[...]. Haematologica 2014
27
50


miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.
Katerina Musilova, Jan Devan, Katerina Cerna, Vaclav Seda, Gabriela Pavlasova, Sonali Sharma, Jan Oppelt, Robert Pytlik, Vit Prochazka, Zuzana Prouzova,[...]. Blood 2018
30
50

The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.
Gabriele Varano, Simon Raffel, Martina Sormani, Federica Zanardi, Silvia Lonardi, Christin Zasada, Laura Perucho, Valentina Petrocelli, Andrea Haake, Albert K Lee,[...]. Nature 2017
48
50

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.
Jimmy Lee, Liang Leo Zhang, Wenjun Wu, Hui Guo, Yan Li, Madina Sukhanova, Girish Venkataraman, Shengjian Huang, Hui Zhang, Mir Alikhan,[...]. Blood Adv 2018
34
50

Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Natalie Put, Katrien Van Roosbroeck, Peter Konings, Peter Meeus, Caroline Brusselmans, Katrina Rack, Carine Gervais, Florence Nguyen-Khac, Elise Chapiro, Isabelle Radford-Weiss,[...]. Ann Hematol 2012
37
50

Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Colleen T Harrington, Elena Sotillo, Aude Robert, Katharina E Hayer, Agata M Bogusz, James Psathas, Duonan Yu, Deanne Taylor, Chi V Dang, Peter S Klein,[...]. Leukemia 2019
12
50

Advances in the understanding of MYC-induced lymphomagenesis.
Kay Klapproth, Thomas Wirth. Br J Haematol 2010
129
50


The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas.
Christian Schuster, Angelika Berger, Maria A Hoelzl, Eva M Putz, Anna Frenzel, Olivia Simma, Nadine Moritz, Andrea Hoelbl, Boris Kovacic, Michael Freissmuth,[...]. Blood 2011
24
50

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
Craig R Soderquist, Nupam Patel, Vundavalli V Murty, Shane Betman, Nidhi Aggarwal, Ken H Young, Luc Xerri, Rebecca Leeman-Neill, Suzanne K Lewis, Peter H Green,[...]. Haematologica 2020
23
50

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.
Wolfram Klapper, Eva Hoster, Olaf Determann, Ilske Oschlies, Jeroen van der Laak, Françoise Berger, Heinz Wolfram Bernd, José Cabeçadas, Elias Campo, Sergio Cogliatti,[...]. J Hematop 2009
114
50

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
John P Leonard, Kathryn S Kolibaba, James A Reeves, Anil Tulpule, Ian W Flinn, Tatjana Kolevska, Robert Robles, Christopher R Flowers, Robert Collins, Nicholas J DiBella,[...]. J Clin Oncol 2017
103
50

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.
Sietse M Aukema, Eva Hoster, Andreas Rosenwald, Danielle Canoni, Marie-Hélène Delfau-Larue, Grzegorz Rymkiewicz, Christoph Thorns, Sylvia Hartmann, Hanneke Kluin-Nelemans, Olivier Hermine,[...]. Blood 2018
72
50

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Steven P Treon, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Patricia Sheehy, Robert J Manning, Christopher J Patterson, Christina Tripsas,[...]. N Engl J Med 2012
806
50

Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
James T Edinger, Jeffrey A Kant, Steven H Swerdlow. Am J Surg Pathol 2010
75
50

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
Alexandar Tzankov, Nora Leu, Simone Muenst, Darius Juskevicius, Dirk Klingbiel, Christoph Mamot, Stephan Dirnhofer. J Hematol Oncol 2015
23
50

Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.
Cecelia Simonelli, Michele Spina, Roberta Cinelli, Renato Talamini, Rosamaria Tedeschi, Annunziata Gloghini, Emanuela Vaccher, Antonio Carbone, Umberto Tirelli. J Clin Oncol 2003
176
50

Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.
Kazuyuki Shimada, Kenichi Yoshida, Yasuhiro Suzuki, Chisako Iriyama, Yoshikage Inoue, Masashi Sanada, Keisuke Kataoka, Masaaki Yuge, Yusuke Takagi, Shigeru Kusumoto,[...]. Blood 2021
25
50

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
Maria Pamela Dobay, Francois Lemonnier, Edoardo Missiaglia, Christian Bastard, David Vallois, Jean-Philippe Jais, Laurianne Scourzic, Aurélie Dupuy, Virginie Fataccioli, Anais Pujals,[...]. Haematologica 2017
88
50


Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.
Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos, Pamela McKay, Tycel Phillips, Sarit Assouline, Connie Lee Batlevi, Phillip Campbell, Vincent Ribrag, Gandhi Laurent Damaj,[...]. Lancet Oncol 2020
142
50

Double-Hit and Triple-Hit Follicular Lymphoma.
Jessica B Ziemba, Zena Wolf, Matthew Weinstock, Saja Asakrah. Am J Clin Pathol 2020
11
50

Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.
Andrés J M Ferreri, Elías Campo, John F Seymour, Rein Willemze, Fiorella Ilariucci, Achille Ambrosetti, Emanuele Zucca, Giuseppe Rossi, Armando López-Guillermo, Miguel A Pavlovsky,[...]. Br J Haematol 2004
390
50

Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18.
Agnieszka Małecka, Jan Delabie, Ingunn Østlie, Anne Tierens, Ulla Randen, Sigbjørn Berentsen, Geir E Tjønnfjord, Gunhild Trøen. Blood Adv 2020
12
50


Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks.
Maurilio Ponzoni, Elias Campo, Shigeo Nakamura. Blood 2018
94
50

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Paul G Kemps, Jennifer Picarsic, Benjamin H Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D van de Wetering, Carel J M van Noesel, Jan A M van Laar, Robert M Verdijk,[...]. Blood 2022
16
50

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
L Cerroni, S Signoretti, G Höfler, G Annessi, B Pütz, E Lackinger, D Metze, A Giannetti, H Kerl. Am J Surg Pathol 1997
155
50

Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma.
Anita Kumar, Zhitao Ying, Anna Alperovich, Ahmet Dogan, Paul Hamlin, Craig Moskowitz, Janine Pichardo, Carol Portlock, Fushen Sha, Andrew D Zelenetz,[...]. Haematologica 2019
10
50

A search for infectious agents in chronic abacterial prostatitis using ultrasound guided biopsy.
A Doble, B J Thomas, P M Furr, M M Walker, J R Harris, R O Witherow, D Taylor-Robinson. Br J Urol 1989
35
50

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Pieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, Saad Usmani, David Siegel, Kenneth C Anderson, Wee-Joo Chng, Philippe Moreau, Michel Attal, Robert A Kyle,[...]. Blood 2016
492
50

Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
Takashi Oyama, Kazuhito Yamamoto, Naoko Asano, Aya Oshiro, Ritsuro Suzuki, Yoshitoyo Kagami, Yasuo Morishima, Kengo Takeuchi, Toshiyuki Izumo, Shigeo Mori,[...]. Clin Cancer Res 2007
310
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.